INS and metabolic syndrome: Many complex mechanisms indicate the association of many hormones and hormones with metabolic syndrome in the pathogenesis of breast cancer, through interactions in signalling pathways involving oestrogen, insulin, growth factors, and cytokines, especially in the postmenopausal case of hormone-dependent cancers [31,32].